A new study found that a shorter time gap between melatonin production and sleep midpoints may be linked to longer survival among women with advanced breast cancer.
May’s FDA approvals include the first at-home HPV test, a blood-based Alzheimer’s diagnostic, biosimilars, AI-enabled imaging tools, and novel therapies across cardiology, pulmonology, neurology, gastroenterology, and more.
A study involving women with dense breast tissue found that an abbreviated breast MRI protocol was as effective as the full version in detecting cancer—while taking less than half the time to complete.
Researchers found that an at-home self-collection device for HPV testing demonstrated high accuracy and safety, matching clinician-collected results for cervical cancer screening.